TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences.
WALTHAM, Mass.,
- Citi’s 13th Annual Biotech Day at the
Four Seasons Hotel inBoston onWednesday, September 5, 2018 .Lonnie Moulder , CEO ofTESARO , andMary Lynne Hedley , Ph.D., President and COO ofTESARO , will discuss the Company’s business and development programs in an analyst-led fireside chat, and importantly, will review recent progress of the Company’s lung cancer strategy for ZEJULA and its immuno-oncology programs. The fireside chat will be webcast onSeptember 5 from12:15 to 1:15 PM ET , andTESARO will also host meetings with investors.
- The Baird 2018 Global Healthcare Conference at the InterContinental New York Barclay in
New York City onWednesday, September 5 .Tim Pearson , Executive Vice President and CFO ofTESARO , andGrant Bogle , Senior Vice President and Chief Commercial Officer ofTESARO , are scheduled to participate in an analyst-led fireside chat from12:15 to 12:45 PM ET onSeptember 5 , and will also host meetings with investors.
The Wells Fargo Global Healthcare Conference at theWestin Copley Place inBoston onThursday, September 6 .Lonnie Moulder andMary Lynne Hedley , Ph.D., are scheduled to present an overview of the Company’s business and development programs at11:30 AM ET onSeptember 6 , and will also host meetings with investors.
Live webcasts of the presentations at the Citi, Baird, and
About
For additional information, please contact:
1.781.325.1116
jdavis@tesarobio.com
1.781.257.2505
krausch@tesarobio.com
